StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note published on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright cut their price target on Aeterna Zentaris from $28.00 to $15.00 and set a buy rating for the company in […]
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Aeterna Zentaris Inc. and Ceapro Inc. is fair to Aeterna shareholders.
Halper Sadeh encourages Aeterna.
By Adriano Marchese Aeterna Zentaris and Ceapro have agreed to merge by way of share-exchange. The two biopharmaceutical development companies said Thursday.
Aeterna Zentaris (AEZS) and Ceapro Announce Merger of Equals streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.